Serum Metal Ion Concentrations Following Primary Hip Arthroplasty
NCT ID: NCT00714610
Last Updated: 2014-02-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
39 participants
OBSERVATIONAL
2007-08-31
2013-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Serum Level of Cobalt and Chromium After Ceramic on Metal Articulation Total Hip Arthroplasty
NCT02346513
Metal Ion Serum Concentrations in Patients With Total Hip Replacements
NCT00156598
Whole Blood Metal Ion Concentrations in Metal-on-metal Total Hip Arthroplasty and Hip Resurfacing
NCT04585022
Ototoxicity in Patients With MoM Hip Bearings
NCT06885411
Metal Ions in Ceramic on Metal Total Hip Arthroplasty
NCT01437124
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The effect of the presence of bilateral large-head MOM THA on circulating metal ions levels has not been thoroughly studied. Metal ion levels in patients with unilateral MOM vs bilateral MOM resurfacing and small-head THA have been reported; however, to the investigators knowledge, no study has investigated the differences in serum metal ion levels in unilateral vs bilateral largehead (≥38 mm) MOM THA. The objective of this study was to compare serum cobalt and chromium levels in patients who have undergone unilateral vs bilateral large-head MOM THA to better understand the effect of the presence of bilateral implants on circulating metal ion levels. The investigators believe that further understanding baseline levels in well-functioning MOM THA will increase the clinical utility of checking serum metal ion levels in the workup of the painful MOM THA. The investigators hypothesis was that serum metal ion levels in patients with well-functioning bilateral large-head MOM THA would be higher than levels in patients with well functioning unilateral large-head MOM THA, but these levels would not approach those seen with metallosis.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Unilateral or bilateral large head metal on metal primary total hip arthroplasty
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* undergone bilateral large-head primary MOM THA
* 18 years old or older
* at least one year out from their index procedure
* had well-positioned components
Exclusion Criteria
* renal insufficiency (estimated creatinine clearance b30 mL/min)
* component malpositioning (cup inclination angle N55°)
* evidence of osteolysis on radiographs
* a poorly functioning hip (Harris Hip Score \[HHS\] b70)
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Utah
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Christopher Peters
M.D.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christopher Peters, MD
Role: PRINCIPAL_INVESTIGATOR
University of Utah Orthopaedic Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Utah Orthopaedic Center
Salt Lake City, Utah, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
21498
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.